Cellectar Biosciences Further Deepens Intellectual Property Portfolio with Patent Grant for PET Imaging PDC

Cellector biosciences Inc., an oncology-focused, clinical stage biotechnology company, announces the United States Patent and Trademark Office has granted a method of use of patent CLR124, the companies cancer imaging agent, which utilizes collectors proprietary phospholipids drug conjugate (PDC) delivery platform. Importance of the patent The recently issued patent, 9,579,406 titled “Phospholipids ether analogs [...]